Home >  Search by Antibiotics > Geneticin (G418)

Geneticin (G418)

 
Cell line Species Tissue Culture medium Cencentration
293 human kidney; fetal Dulbecco's modified Eagle's medium 2000 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 400 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 1000 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 700 (μg/ml)
293 human kidney; fetal Minimal essential medium 400 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 400 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 500 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 150 (μg/ml)
293 human kidney; fetal Minimal essential medium 400 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 450 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 400 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 500 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia RPMI 1640 Medium 500 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia RPMI 1640 Medium 700 (μg/ml)
CHO-K1 hamster, Chinese ovary Dulbecco's modified Eagle's medium 1000 (μg/ml)
AtT20 Dulbecco's modified Eagle's medium 800 (μg/ml)
AtT-20 mouse pituitary tumor Dulbecco's modified Eagle's medium 400 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 800 (μg/ml)
293 human kidney; fetal Minimal essential medium 400 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 400 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 400 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 350 (μg/ml)
RBL rat Dulbecco's modified Eagle's medium 1000 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 250 (μg/ml)
Non-CHO RPMI 1640 Medium 800 (μg/ml)
NCI-H1299 human lymph node (metastasis); large cell neuroendocrine carcinoma (lung primary) Dulbecco's modified Eagle's medium 700 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 800 (μg/ml)
143B human bone; osteosarcoma Dulbecco's modified Eagle's medium 400 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 800 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 800 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 800 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 800 (μg/ml)
293T human Kidney (embryonic) Dulbecco's modified Eagle's medium 400 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 100 (units/ml)
Saos-2 human bone; osteosarcoma Dulbecco's modified Eagle's medium 300 (μg/ml)
E11 (HCT-8 variant) human colon RPMI 1640 Medium 800 (μg/ml)
A549 human Lungcarcinoma RPMI 1640 Medium 700 (μg/ml)
A549 human Lungcarcinoma RPMI 1640 Medium 500 (μg/ml)
D3 Dulbecco's modified Eagle's medium 1500 (μg/ml)
FE-8 Dulbecco's modified Eagle's medium 200 (μg/ml)
AR42J rat exocrine pancreas; tumor Dulbecco's modified Eagle's medium 800 (μg/ml)
NIH3T3 mouse embryo Dulbecco's modified Eagle's medium 800 (μg/ml)
NG108-15 mouse/rat brain; glial cell; neuron; glioblastoma; neuroblastoma (hybrid) Dulbecco's modified Eagle's medium 1000-1300 (μg/ml)
AtT-20 mouse pituitary tumor Dulbecco's modified Eagle's medium 500 (μg/ml)
PC12 Dulbecco's modified Eagle's medium 1 (mg/ml)
WEHI-231 mouse B lymphocyte; lymphoma RPMI 1640 Medium 600 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 1 (mg/ml)
AtT-20 mouse pituitary tumor Dulbecco's modified Eagle's medium 600 (μg/ml)
AtT-20 mouse pituitary tumor Dulbecco's modified Eagle's medium 100 (μg/ml)
AtT-20 mouse pituitary tumor Dulbecco's modified Eagle's medium 1.5 (μg/ml)
CHO hamster, Chinese ovary Dulbecco's modified Eagle's medium 800 (μg/ml)
CHO hamster, Chinese ovary Dulbecco's modified Eagle's medium 1000 (μg/ml)
AtT-20 mouse pituitary tumor Dulbecco's modified Eagle's medium 200 (μg/ml)
A9 L Dulbecco's modified Eagle's medium 500 (μg/ml)
CD40-B Iscove's modified Dulbecco's medium 1000 (μg/ml)
A9 mouse/mouse hybridoma Dulbecco's modified Eagle's medium 500 (μg/ml)
PRO RPMI 1640 Medium 1200 (μg/ml)
HCC Dulbecco's modified Eagle's medium 300 (μg/ml)
BEL-7402 RPMI 1640 Medium 500 (μg/ml)
SPC-A1 Dulbecco's modified Eagle's medium 800 (μg/ml)
HCC Dulbecco's modified Eagle's medium 200 (μg/ml)
Hep G2 human liver; hepatocellular carcinoma Dulbecco's modified Eagle's medium 700 (μg/ml)
Hep3B Minimal essential with Hank's salts 600 (μg/ml)
BARF0 RPMI 1640 Medium 400 (μg/ml)
293 human kidney; fetal RPMI 1640 Medium 400 (μg/ml)
293 human kidney; fetal RPMI 1640 Medium 400 (μg/ml)
293 human kidney; fetal RPMI 1640 Medium 800 (μg/ml)
B95-8 Iscove's minimal essential medium 500 (μg/ml)
BT-474 human mammary gland; ductal carcinoma Dulbecco's modified Eagle's medium 4000 (μg/ml)
293T human Kidney (embryonic) Dulbecco's modified Eagle's medium 800 (μg/ml)
DG75 RPMI 1640 Medium 700 (μg/ml)
MCF7 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) Dulbecco's modified Eagle's medium 200 (μg/ml)
C666 RPMI 1640 Medium 200 (μg/ml)
T2 (174 x CEM.T2) human/human lymphoblast cell hybrid RPMI 1640 Medium 600 (μg/ml)
Akata RPMI 1640 Medium 700 (μg/ml)
293 human kidney; fetal RPMI 1640 Medium 700 (μg/ml)
BL RPMI 1640 Medium 300 (μg/ml)
PEL RPMI 1640 Medium 300 (μg/ml)
A904L RPMI 1640 Medium 300 (μg/ml)
TW01 RPMI 1640 Medium 1000 (μg/ml)
B95-8 RPMI 1640 Medium 3000 (μg/ml)
B95-8 Fetal bovine serum/ Fetal Calf Serum 800000 (μg/ml)
HONE-1 Dulbecco's modified Eagle's medium 200 (μg/ml)
HeLa human cervix; adenocarcinoma 800 (μg/ml)
MCF7 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) 800 (mg/ml)
A9 mouse/mouse hybridoma Dulbecco's modified Eagle's medium 1 (mg/ml)
HONE-1 Dulbecco's modified Eagle's medium 1 (mg/ml)
PA317 mouse embryo; amphotropic retroviral packaging line Dulbecco's modified Eagle's medium 200 (μg/ml)
EC9706 500 (μg/ml)
SLMT-1 Dulbecco's modified Eagle's medium 800 (μg/ml)
TGR-1 800 (μg/ml)
RD human muscle; rhabdomyosarcoma Dulbecco's modified Eagle's medium 100 (μg/ml)
A9 mouse/mouse hybridoma Dulbecco's modified Eagle's medium 500 (μg/ml)
PC-3 human bone (metastasis); adenocarcinoma (prostate primary) Ham’s F-12 nutrient mixture 1000 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 1500 (μg/ml)
Bosc23 Dulbecco's modified Eagle's medium 300 (μg/ml)
3T3 mouse embryonic fibroblast Dulbecco's modified Eagle's medium 1000 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 500 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 400 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 650 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 650 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 400 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 400 (μg/ml)
LNCaP human prostatic adenocarcinoma Dulbecco's modified Eagle's medium 800 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 400 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 500 (μg/ml)
3T3-L1-TET Dulbecco's modified Eagle's medium 35 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 500 (μg/ml)
293T human Kidney (embryonic) Dulbecco's modified Eagle's medium 500 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 800 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 400 (μg/ml)
PC12 Dulbecco's modified Eagle's medium 250 (μg/ml)
MCF7 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) Dulbecco's modified Eagle's medium 400 (μg/ml)
MDA-468 human Dulbecco's modified Eagle's medium 1000 (μg/ml)
BT-20 human mammary gland; carcinoma Eagle's minimal essential medium 400 (μg/ml)
MCF-12A human mammary gland Dulbecco's modified Eagle's medium 600 (μg/ml)
GP+E-86 mouse embryo; amphotropic retroviral packaging line Dulbecco's modified Eagle's medium 400 (μg/ml)
L02 human Dulbecco's modified Eagle's medium 600 (μg/ml)
CHO hamster, Chinese ovary α-modified minimal essential medium 800 (μg/ml)
GLC-82 human lung RPMI 1640 Medium 500 (μg/ml)
ARIP rat exocrine pancreas; tumor 400 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 400 (μg/ml)
HCC Eagle's minimal essential medium 800 (μg/ml)
AN3 CA human lymph node (metastasis); adenocarcinoma (endometrium primary) 550 (μg/ml)
BeWo human placenta; choriocarcinoma Ham’s F-12 nutrient mixture 300 (μg/ml)
CHO-K1 hamster, Chinese ovary Eagle's minimal essential medium 500 (μg/ml)
BeWo human placenta; choriocarcinoma Dulbecco's modified Eagle's medium 400 (μg/ml)
CHO hamster, Chinese ovary Ham’s F-12 nutrient mixture 500 (μg/ml)
BeWo human placenta; choriocarcinoma 800 (μg/ml)
BOSC Dulbecco's modified Eagle's medium 400 (μg/ml)
BeWo human placenta; choriocarcinoma Ham’s F-12 nutrient mixture 500 (μg/ml)
AtT-20 mouse pituitary tumor Dulbecco's modified Eagle's medium 700 (μg/ml)
AtT-20 mouse pituitary tumor Dulbecco's modified Eagle's medium 700 (μg/ml)
JEG-3 human placenta; choriocarcinoma Eagle's minimal essential medium 1000 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 1000 (μg/ml)
GH4 rat Dulbecco's modified Eagle's medium 800 (μg/ml)
AtT-20 mouse pituitary tumor Dulbecco's modified Eagle's medium 500 (μg/ml)
SK-HEP-1 human ascites (metastasis); adenocarcinoma (liver primary) Dulbecco's modified Eagle's medium 500 (μg/ml)
GH3 rat pituitary tumor Ham's F-10 800 (μg/ml)
AtT-20 mouse pituitary tumor Dulbecco's modified Eagle's medium 300 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 700 (μg/ml)
C6 rat brain; glioma Dulbecco's modified Eagle's medium 1000 (μg/ml)
C2C12 mouse muscle Dulbecco's modified Eagle's medium 500 (μg/ml)
ME-180 human omentum (metastasis); epidermoid carcinoma (cervix primary) RPMI 1640 Medium 1000 (μg/ml)
A549 human Lungcarcinoma Dulbecco's modified Eagle's medium 600 (μg/ml)
U-87 MG Dulbecco's modified Eagle's medium 750 (μg/ml)
BT-549 human mammary gland; ductal carcinoma Dulbecco's modified Eagle's medium 750 (μg/ml)
JEG-3 human placenta; choriocarcinoma Dulbecco's modified Eagle's medium 500 (μg/ml)
C166 mouse (transgenic) yolk sac; endothelial cell differentiation model; stem cell feeder layer Minimal essential medium 800 (μg/ml)
T-47D human pleural effusion (metastasis); ductal carcinoma (mammary gland primary) RPMI 1640 Medium 800 (μg/ml)
BT-20 human mammary gland; carcinoma Eagle's minimal essential medium 250 (μg/ml)
A20 mouse B lymphocyte; reticulum cell sarcoma RPMI 1640 Medium 400 (μg/ml)
HeLa human cervix; adenocarcinoma 400 (μg/ml)
DU 145 human brain (metastasis); carcinoma (prostate primary) Dulbecco's modified Eagle's medium 200 (μg/ml)
BT bovine turbinate Dulbecco's modified Eagle's medium 400 (μg/ml)
BeWo human placenta; choriocarcinoma Ham’s F-12 nutrient mixture 200 (μg/ml)
Hep G2 human liver; hepatocellular carcinoma 400 (μg/ml)
HeLa human cervix; adenocarcinoma Eagle's minimal essential medium 500 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 400 (μg/ml)
LLC-PK1 pig kidney Charcoal-stripped fetal bovine serum 1500 (μg/ml)
OK opossum kidney (cortex); proximal tubule DMEM + F12 medium 400 (μg/ml)
BeWo human placenta; choriocarcinoma Ham’s F-12 nutrient mixture 1 (mg/ml)
BRL 3A rat liver Dulbecco's modified Eagle's medium 200 (μg/ml)
BRL 3A rat liver Dulbecco's modified Eagle's medium 800 (μg/ml)
BRL 3A rat liver Dulbecco's modified Eagle's medium 500 (μg/ml)
COLO 320HSR human colon; colorectal adenocarcinoma RPMI 1640 Medium 400 (μg/ml)
BALB/3T3 clone A31 mouse embryo Dulbecco's modified Eagle's medium 250 (μg/ml)
T-47D human pleural effusion (metastasis); ductal carcinoma (mammary gland primary) RPMI 1640 Medium 400 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 650 (μg/ml)
BALB/3T3 clone A31 mouse embryo Dulbecco's modified Eagle's medium 2000 (μg/ml)
3T3 mouse embryonic fibroblast Dulbecco's modified Eagle's medium 200 (μg/ml)
BALB/3T3 clone A31 mouse embryo Dulbecco's modified Eagle's medium 400 (μg/ml)
Saos-2 human bone; osteosarcoma Dulbecco's modified Eagle's medium 400 (μg/ml)
NIH3T3 mouse embryo Dulbecco's modified Eagle's medium 400 (μg/ml)
U-87 MG Dulbecco's modified Eagle's medium 400 (μg/ml)
CHO hamster, Chinese ovary α-modified minimal essential medium 400 (μg/ml)
MG-63 human bone; osteosarcoma Dulbecco's modified Eagle's medium 400 (μg/ml)
SW 1353 human bone; chondrosarcoma α-modified minimal essential medium 500 (μg/ml)
A-204 human muscle; rhabdomyosarcoma Dulbecco's modified Eagle's medium 500 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 600 (μg/ml)
MC3T3-E1 Subclone 4 mouse bone (metastasis); osteosarcoma (femur primary) Dulbecco's modified Eagle's medium 500 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 500 (μg/ml)
BALB/3T3 clone A31 mouse embryo Dulbecco's modified Eagle's medium 500 (μg/ml)
MDA-MB-436 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) α-modified minimal essential medium 125 (μg/ml)
BALB/3T3 clone A31 mouse embryo Dulbecco's modified Eagle's medium 100 (μg/ml)
M1 mouse myeloblast; myeloid leukemia Dulbecco's modified Eagle's medium 100 (μg/ml)
Rat1-R12 rat connective tissue Dulbecco's modified Eagle's medium 1000 (μg/ml)
Rat1-R12 rat connective tissue Dulbecco's modified Eagle's medium 1000 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 1000 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 1000 (μg/ml)
BALB/3T3 clone A31 mouse embryo Dulbecco's modified Eagle's medium 500 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 500 (μg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney α-modified minimal essential medium 800 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 780 (μg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney Dulbecco's modified Eagle's medium 780 (μg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney Eagle's minimal essential medium 1000 (μg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney 500 (μg/ml)
CHO-K1 hamster, Chinese ovary Dulbecco's modified Eagle's medium 500 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 1 (mg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney Eagle's minimal essential medium 800 (μg/ml)
NCI-H1299 human lymph node (metastasis); large cell neuroendocrine carcinoma (lung primary) Dulbecco's modified Eagle's medium 800 (μg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney GMEM medium 1 (mg/ml)
MDA-MB-468 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) Minimal essential medium 2 (μg/ml)
HBL-100 Dulbecco's modified Eagle's medium 1000 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 800 (μg/ml)
U-87 MG α-modified minimal essential medium 600 (μg/ml)
JEG-3 human placenta; choriocarcinoma Eagle's minimal essential medium 1500 (μg/ml)
HeLa human cervix; adenocarcinoma DMEM + F12 medium 600 (μg/ml)
K-562 human pleural effusion (metastatic); chronic myelo-genous leukemia (bone marrow primary) RPMI 1640 Medium 600 (μg/ml)
N2a DMEM + F12 medium 200 (μg/ml)
B16 Murine melanoma DMEM + F12 medium 600 (μg/ml)
JEG-3 human placenta; choriocarcinoma Eagle's minimal essential medium 300 (μg/ml)
NCI-H295 human adrenal gland; cortex adrenocortical carcinoma 400 (μg/ml)
CHO hamster, Chinese ovary Eagle's minimal essential medium 600 (μg/ml)
B95-8 RPMI 1640 Medium 0.5 (μg/ml)
Akata RPMI 1640 Medium 400 (μg/ml)
A904L Dulbecco's modified Eagle's medium 800 (μg/ml)
B95-8 RPMI 1640 Medium 1200 (μg/ml)
BJAB Dulbecco's modified Eagle's medium 400 (μg/ml)
B95-8 RPMI 1640 Medium 600 (μg/ml)
Bing human kidney; amphotropic retroviral packaging line Dulbecco's modified Eagle's medium 800 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 800 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 800 (μg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney Dulbecco's modified Eagle's medium 800 (μg/ml)
3T3 mouse embryonic fibroblast 800 (μg/ml)
NIH3T3 mouse embryo Dulbecco's modified Eagle's medium 800 (μg/ml)
NIH3T3 mouse embryo Dulbecco's modified Eagle's medium 500 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 500 (μg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney Dulbecco's modified Eagle's medium 800 (μg/ml)
CHO hamster, Chinese ovary DMEM + F12 medium 800 (μg/ml)
MDA-MB-231 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) Eagle's minimal essential medium 400 (μg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney Dulbecco's modified Eagle's medium 1 (mg/ml)
MCF7 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) Dulbecco's modified Eagle's medium 600 (μg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney Dulbecco's modified Eagle's medium 400 (μg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney Dulbecco's modified Eagle's medium 400 (μg/ml)
HeLa human cervix; adenocarcinoma Eagle's minimal essential medium 400 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 800 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 700 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 300 (μg/ml)
PANC-1 human pancreas (duct); epithelioid carcinoma Minimal essential medium 550 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma DMEM + F12 medium 230 (μg/ml)
A431NS human epidermis; epidermoid carcinoma Dulbecco's modified Eagle's medium 800 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma Minimal essential medium 1 (mg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 500 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 200 (μg/ml)
BJ human skin (foreskin) Dulbecco's modified Eagle's medium 400 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 1000 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 400 (μg/ml)
A253 human epidermis; epidermoid carcinoma RPMI 1640 Medium 800 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 1000 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 1000 (μg/ml)
LNCaP human prostatic adenocarcinoma RPMI 1640 Medium 1000 (μg/ml)
LNCaP human prostatic adenocarcinoma RPMI 1640 Medium 1000 (μg/ml)
NIH3T3 mouse embryo Dulbecco's modified Eagle's medium 100 (μg/ml)
COS-7 monkey, African green kidney RPMI 1640 Medium 3000 (μg/ml)
HT-1080 human connective tissue; fibrosarcoma RPMI 1640 Medium 400 (μg/ml)
LNCaP human prostatic adenocarcinoma RPMI 1640 Medium 1500 (μg/ml)
NIH3T3 mouse embryo Dulbecco's modified Eagle's medium 500 (μg/ml)
NIH3T3 mouse embryo Dulbecco's modified Eagle's medium 50000 (μg/ml)
NIH3T3 mouse embryo DMEM + F12 medium 1500 (μg/ml)
AGS human stomach; gastric adenocarcinoma RPMI 1640 Medium 400 (μg/ml)
NIH3T3 mouse embryo Dulbecco's modified Eagle's medium 400 (μg/ml)
MCF 10A human mammary gland; fibrocystic disease Dulbecco's modified Eagle's medium 1000 (μg/ml)
MCF 10A human mammary gland; fibrocystic disease Dulbecco's modified Eagle's medium 1000 (μg/ml)
A-431 human epidermis; epidermoid carcinoma Dulbecco's modified Eagle's medium 800 (μg/ml)
A-431 human epidermis; epidermoid carcinoma Minimal essential medium 400 (μg/ml)
A-431 human epidermis; epidermoid carcinoma Dulbecco's modified Eagle's medium 400 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 1 (mg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 400 (μg/ml)
PC12 Dulbecco's modified Eagle's medium 400 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 1500 (μg/ml)
DT40 chicken bursa; lymphoma RPMI 1640 Medium 350 (μg/ml)
DT40 chicken bursa; lymphoma RPMI 1640 Medium 500 (μg/ml)
NRK-52E rat kidney Dulbecco's modified Eagle's medium 500 (μg/ml)
293 human kidney; fetal 10 (μg/ml)
NIH/3T3 mouse embryo Ham’s F-12 nutrient mixture 1000 (μg/ml)
MDCK (NBL-2) dog kidney Dulbecco's modified Eagle's medium 500 (μg/ml)
A-431 human epidermis; epidermoid carcinoma Dulbecco's modified Eagle's medium 400 (μg/ml)
GP+envAM-12 mouse embryo; amphotropic retroviral packaging line Dulbecco's modified Eagle's medium 600 (μg/ml)
RAW 264.7 mouse monocyte; macrophage; AMLV-induced tumor 2500 (μg/ml)
NIH/3T3 mouse embryo 600 (μg/ml)
PT67 mouse embryo; amphotropic retroviral packaging line 500 (μg/ml)
MDCK (NBL-2) dog kidney Dulbecco's modified Eagle's medium 400 (μg/ml)
CHO hamster, Chinese ovary 500 (μg/ml)
U-2 OS human bone; osteosarcoma RPMI 1640 Medium 600 (μg/ml)
CHO-K1 hamster, Chinese ovary 700 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 600 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 800 (μg/ml)
A-431 human epidermis; epidermoid carcinoma α-modified minimal essential medium 800 (μg/ml)
A-431 human epidermis; epidermoid carcinoma Dulbecco's modified Eagle's medium 500 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 800 (μg/ml)
CHO-K1 hamster, Chinese ovary 400 (μg/ml)
CHO-K1 hamster, Chinese ovary 800 (μg/ml)
NIH3T3 mouse embryo Earle’s balanced salt solution medium 1000 (μg/ml)
LNCaP human prostatic adenocarcinoma Dulbecco's modified Eagle's medium 1000 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 500 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia Dulbecco's modified Eagle's medium 500 (μg/ml)
PC12 Dulbecco's modified Eagle's medium 800 (μg/ml)
CHO-K1 hamster, Chinese ovary Dulbecco's modified Eagle's medium 2000 (μg/ml)
C2C12 mouse muscle Dulbecco's modified Eagle's medium 4000 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia RPMI 1640 Medium 800 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 400 (μg/ml)
CHO-K1 hamster, Chinese ovary Dulbecco's modified Eagle's medium 600 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 70 (μg/ml)
MDCK (NBL-2) dog kidney Eagle's minimal essential medium 400 (μg/ml)
STO mouse embryo Dulbecco's modified Eagle's medium 800 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 1 (mg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia RPMI 1640 Medium 700 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 600 (μg/ml)
ES cell Dulbecco's modified Eagle's medium 400 (μg/ml)
CHO-K1 hamster, Chinese ovary DMEM + F12 medium 800 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 800 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 400 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 800 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 400 (μg/ml)
CHO-K1 hamster, Chinese ovary Dulbecco's modified Eagle's medium 500 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 500 (μg/ml)
H9 human RPMI 1640 Medium 1000 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia RPMI 1640 Medium 75 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 400 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 500 (μg/ml)
NRK rat kidney Dulbecco's modified Eagle's medium 200 (μg/ml)
COS-7 monkey, African green kidney Dulbecco's modified Eagle's medium 400 (μg/ml)
GP+envAM-12 mouse embryo; amphotropic retroviral packaging line Dulbecco's modified Eagle's medium 800 (μg/ml)
H9 human RPMI 1640 Medium 400 (μg/ml)
SCC-15 human tongue; squamous cell carcinoma 500 (μg/ml)
RGC-5 Dulbecco's modified Eagle's medium 800 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 400 (μg/ml)
HT-1080 human connective tissue; fibrosarcoma Dulbecco's modified Eagle's medium 250 (μg/ml)
GH3 rat pituitary tumor Dulbecco's modified Eagle's medium 400 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 500 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 350 (μg/ml)
NIH3T3 mouse embryo Dulbecco's modified Eagle's medium 600 (μg/ml)
BJAB RPMI 1640 Medium 600 (μg/ml)
hESCs KO-DMEM 2000 (μg/ml)
CHO-K1 hamster, Chinese ovary DMEM + F12 medium 500 (μg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney Dulbecco's modified Eagle's medium 1000 (μg/ml)
CHO-K1 hamster, Chinese ovary 800 (μg/ml)
CHO-K1 hamster, Chinese ovary α-modified minimal essential medium 400 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 400 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 2000 (μg/ml)
GH3 rat pituitary tumor Dulbecco's modified Eagle's medium 500 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 500 (μg/ml)
CHO-K1 hamster, Chinese ovary DMEM / F 12 medium 150 (μg/ml)
CD38 RPMI 1640 Medium 800 (μg/ml)
H9 human Dulbecco's modified Eagle's medium 750 (μg/ml)
P19 mouse embryo; teratocarcinoma; embryonic carcinoma Dulbecco's modified Eagle's medium 500 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 500 (μg/ml)
CHO-K1 hamster, Chinese ovary Minimal essential medium 800 (μg/ml)
GH3 rat pituitary tumor DMEM + F12 medium 1 (mg/ml)
Caco-2 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 200 (μg/ml)
GH3 rat pituitary tumor DMEM + F12 medium 1000 (μg/ml)
CHO-K1 hamster, Chinese ovary DMEM + F12 medium 400 (μg/ml)
CHO-K1 hamster, Chinese ovary DMEM + F12 medium 200 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 400 (μg/ml)
CHO-K1 hamster, Chinese ovary Dulbecco's modified Eagle's medium 1 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 400 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 400 (μg/ml)
MCF7 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) RPMI 1640 Medium 500 (μg/ml)
COS-7 monkey, African green kidney RPMI 1640 Medium 500 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 400 (μg/ml)
SCC-25 human tongue; squamous cell carcinoma DMEM + F12 medium 400 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia RPMI 1640 Medium 400 (μg/ml)
NIH3T3 mouse embryo 400 (μg/ml)
GH3 rat pituitary tumor Dulbecco's modified Eagle's medium 1 (μg/ml)
GH3 rat pituitary tumor Dulbecco's modified Eagle's medium 400 (μg/ml)
CHO hamster, Chinese ovary Dulbecco's modified Eagle's medium 400 (μg/ml)
CHO hamster, Chinese ovary α-modified minimal essential medium 375 (μg/ml)
GH3 rat pituitary tumor Dulbecco's modified Eagle's medium 400 (μg/ml)
PT67 mouse embryo; amphotropic retroviral packaging line DMEM + F12 medium 800 (μg/ml)
CHO hamster, Chinese ovary Ham’s F-12 nutrient mixture 1000 (μg/ml)
MDA-MB-231 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) Dulbecco's modified Eagle's medium 700 (μg/ml)
MCF 10A human mammary gland; fibrocystic disease DMEM / F 12 medium 0.75 (μg/ml)
JEG-3 human placenta; choriocarcinoma α-modified minimal essential medium 400 (μg/ml)
32D Clone 3 mouse bone marrow RPMI 1640 Medium 600 (μg/ml)
32D Clone 3 mouse bone marrow RPMI 1640 Medium 2000 (μg/ml)
LS 174T human colon; colorectal adenocarcinoma RPMI 1640 Medium 800 (μg/ml)
293T human Kidney (embryonic) Dulbecco's modified Eagle's medium 700 (μg/ml)
CHO hamster, Chinese ovary Dulbecco's modified Eagle's medium 500 (μg/ml)
HeLa S3 human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 500 (μg/ml)
DLD-1 human colon; colorectal adenocarcinoma RPMI 1640 Medium 400 (μg/ml)
SH-SY5Y human bone marrow (metastasis); neuroblastoma (brain primary) Dulbecco's modified Eagle's medium 500 (μg/ml)
293 human kidney; fetal 500 (μg/ml)
CHO hamster, Chinese ovary Dulbecco's modified Eagle's medium 250 (μg/ml)
CRFK cat kidney (cortex) RPMI 1640 Medium 500 (μg/ml)
D17 dog bone; osteosarcoma RPMI 1640 Medium 600 (μg/ml)
JEG-3 human placenta; choriocarcinoma DMEM / F 12 medium 250 (μg/ml)
BeWo human placenta; choriocarcinoma Dulbecco's modified Eagle's medium 750 (μg/ml)
JAR human placenta; choriocarcinoma 1000 (μg/ml)
JEG-3 human placenta; choriocarcinoma 750 (μg/ml)
MDA-MB-231 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) Minimal essential medium 400 (μg/ml)
JEG-3 human placenta; choriocarcinoma Minimal essential medium 400 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 800 (μg/ml)
BT-20 human mammary gland; carcinoma RPMI 1640 Medium 1200 (μg/ml)
BT-20 human mammary gland; carcinoma RPMI 1640 Medium 400 (μg/ml)
JEG-3 human placenta; choriocarcinoma 100 (μg/ml)
CHO hamster, Chinese ovary 500 (μg/ml)
C2C12 mouse muscle 500 (μg/ml)
293 human kidney; fetal 600 (μg/ml)
HeLa human cervix; adenocarcinoma 500 (μg/ml)
Hep3B 600 (μg/ml)
Hep G2 human liver; hepatocellular carcinoma 500 (μg/ml)
NIH/3T3 mouse embryo 1000 (μg/ml)
BALB/3T3 clone A31 mouse embryo Dulbecco's modified Eagle's medium 1500 (μg/ml)
Rat1-R12 rat connective tissue 1500 (μg/ml)
293T human Kidney (embryonic) 500 (μg/ml)
GP+E-86 mouse embryo; amphotropic retroviral packaging line 1000 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 400 (μg/ml)
CHO hamster, Chinese ovary α-modified minimal essential medium 500 (μg/ml)
U-2 OS human bone; osteosarcoma 500 (μg/ml)
Sf9 armyworm, fall ovary SF900 II serum free medium 350 (μg/ml)
H9 human Dulbecco's modified Eagle's medium 400 (μg/ml)
Saos-2 human bone; osteosarcoma Dulbecco's modified Eagle's medium 1 (mg/ml)
SC human peripheral blood; macrophage; monocyte Dulbecco's modified Eagle's medium 400 (μg/ml)
JB6 Cl 41-5a mouse skin (epidermis); chemically transformed Eagle's minimal essential medium 800 (μg/ml)
MCF7 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) Dulbecco's modified Eagle's medium 400 (μg/ml)
CHO hamster, Chinese ovary Dulbecco's modified Eagle's medium 400 (μg/ml)
LMH chicken liver; hepatocellular carcinoma DMEM / F 12 medium 800 (μg/ml)
MCF7 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) Dulbecco's modified Eagle's medium 400 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 500 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 500 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 400 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 400 (μg/ml)
SW480 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 1000 (μg/ml)
KB human HeLa contaminant Dulbecco's modified Eagle's medium 1000 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia 600 (μg/ml)
NIH/3T3 mouse embryo 2 (mg/ml)
293 human kidney; fetal Minimal essential medium 800 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia RPMI 1640 Medium 150 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia Dulbecco's modified Eagle's medium 62.5 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia 750 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia RPMI 1640 Medium 1000 (μg/ml)
RAW 264.7 mouse monocyte; macrophage; AMLV-induced tumor Dulbecco's modified Eagle's medium 500 (μg/ml)
CHO-K1 hamster, Chinese ovary Dulbecco's modified Eagle's medium 1000 (μg/ml)
DLD-1 human colon; colorectal adenocarcinoma RPMI 1640 Medium 1000 (μg/ml)
HEp-2 human HeLa contaminant Dulbecco's modified Eagle's medium 1000 (μg/ml)
PA317 mouse embryo; amphotropic retroviral packaging line Dulbecco's modified Eagle's medium 1000 (μg/ml)
A549 human Lungcarcinoma Dulbecco's modified Eagle's medium 1000 (μg/ml)
293T human Kidney (embryonic) Dulbecco's modified Eagle's medium 1000 (μg/ml)
293T human Kidney (embryonic) Dulbecco's modified Eagle's medium 1000 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia Dulbecco's modified Eagle's medium 1 (mg/ml)
HuT 78 human T lymphocyte; cutaneous; lymphoma Dulbecco's modified Eagle's medium 1000 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia 1000 (μg/ml)
A-498 human kidney; carcinoma Dulbecco's modified Eagle's medium 1000 (μg/ml)
MCF7 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) Iscove's modified Dulbecco's medium 400 (μg/ml)
BT-474 human mammary gland; ductal carcinoma Dulbecco's modified Eagle's medium 200 (μg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney Dulbecco's modified Eagle's medium 400 (μg/ml)
T24 human urinary bladder; transitional cell carcinoma Dulbecco's modified Eagle's medium 50 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 500 (μg/ml)
Clone 9 rat liver DMEM / F 12 medium 600 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 425 (μg/ml)
CHO hamster, Chinese ovary Dulbecco's modified Eagle's medium 300 (μg/ml)
U-937 human macrophage; histiocytic lymphoma RPMI 1640 Medium 500 (μg/ml)
DLD-1 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 600 (μg/ml)
MDCK (NBL-2) dog kidney 400 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 1200 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 200 (μg/ml)
COS-1 monkey, African green kidney Dulbecco's modified Eagle's medium 1000 (μg/ml)
Namalwa KJM-1 Dulbecco's modified Eagle's medium 600 (μg/ml)
COX-2 RPMI 1640 Medium 350 (μg/ml)
293 human kidney; fetal Minimal essential medium 400 (μg/ml)
GLC-45 Dulbecco's modified Eagle's medium 600 (μg/ml)
CHO-K1 hamster, Chinese ovary DMEM / F 12 medium 600 (μg/ml)
COS-1 monkey, African green kidney Dulbecco's modified Eagle's medium 400 (μg/ml)
U-2 OS human bone; osteosarcoma 400 (μg/ml)
COS-1 monkey, African green kidney Dulbecco's modified Eagle's medium 600 (μg/ml)
N2a Dulbecco's modified Eagle's medium 560 (μg/ml)
COS-1 monkey, African green kidney Dulbecco's modified Eagle's medium 1000 (μg/ml)
MDCK (NBL-2) dog kidney Dulbecco's modified Eagle's medium 800 (μg/ml)
Neuro-2a mouse brain; neuroblast; neuroblastoma Dulbecco's modified Eagle's medium 1000 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 1400 (μg/ml)
DT40 chicken bursa; lymphoma RPMI 1640 Medium 1000 (μg/ml)
HeLa S3 human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 300 (μg/ml)
SIRC (Statens Seruminstitut Rabbit Cornea) rabbit eye (cornea) Dulbecco's modified Eagle's medium 600 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 200 (μg/ml)
HeLa human cervix; adenocarcinoma Minimal essential medium 1000 (μg/ml)
ES-E14TG2a mouse embryonic stem cell; pluripotent; HGRPT deficient 200 (μg/ml)
HeLa S3 human cervix; adenocarcinoma 800 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 400 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 800 (μg/ml)
MCF7 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) Minimal essential medium 0.1 (μg/ml)
MDA-MB-435 human breast Minimal essential medium 1000 (μg/ml)
RD human muscle; rhabdomyosarcoma Dulbecco's modified Eagle's medium 100 (μg/ml)
HeLa human cervix; adenocarcinoma RPMI 1640 Medium 100 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 1000 (μg/ml)
CRFK cat kidney (cortex) Dulbecco's modified Eagle's medium 2000 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 2000 (μg/ml)
H1299 human lung RPMI 1640 Medium 500 (μg/ml)
Hep 3B2.1-7 human liver; hepatocellular carcinoma Minimal essential medium 500 (μg/ml)
PLC/PRF/5 human liver; Alexander cells; hepatoma Dulbecco's modified Eagle's medium 400 (μg/ml)
Hep 3B2.1-7 human liver; hepatocellular carcinoma Eagle's minimal essential medium 2000 (μg/ml)
Hep 3B2.1-7 human liver; hepatocellular carcinoma Minimal essential medium 2 (mg/ml)
CHO/dhFr hamster, Chinese ovary; deficient in dihydrofolate reductase α-modified minimal essential medium 1000 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 1500 (μg/ml)
K-562 human pleural effusion (metastatic); chronic myelo-genous leukemia (bone marrow primary) Dulbecco's modified Eagle's medium 850 (μg/ml)
Hs27 human skin (foreskin) Dulbecco's modified Eagle's medium 850 (μg/ml)
32D Clone 3 mouse bone marrow Dulbecco's modified Eagle's medium 500 (μg/ml)
HeLa human cervix; adenocarcinoma Minimal essential medium 800 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 400 (μg/ml)
CV-1 monkey, African green kidney Dulbecco's modified Eagle's medium 800 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 600 (μg/ml)
COLO 320DM human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 300 (μg/ml)
COLO 320HSR human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 400 (μg/ml)
COLO 320HSR human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 600 (μg/ml)
NIH/3T3 mouse embryo 500 (μg/ml)
FRTL rat thyroid 600 (μg/ml)
QT6 quail, Japanese fibrosarcoma 800 (μg/ml)
32D Clone 3 mouse bone marrow 1000 (μg/ml)
32D Clone 3 mouse bone marrow 1000 (μg/ml)
PC12 Dulbecco's modified Eagle's medium 700 (μg/ml)
32D Clone 3 mouse bone marrow 600 (μg/ml)
SW480 human colon; colorectal adenocarcinoma 500 (μg/ml)
32D Clone 3 mouse bone marrow 200 (μg/ml)
Bosc23 500 (μg/ml)
293 human kidney; fetal Minimal essential medium 900 (μg/ml)
BJAB RPMI 1640 Medium 250 (μg/ml)
293 human kidney; fetal 250 (μg/ml)
RBL-1 rat peripheral blood; basophil; leukemia 400 (μg/ml)
32D Clone 3 mouse bone marrow 800 (μg/ml)
32D Clone 3 mouse bone marrow 800 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 400 (μg/ml)
LLC-PK1 pig kidney 500 (μg/ml)
M1 mouse myeloblast; myeloid leukemia 600 (μg/ml)
COS-1 monkey, African green kidney RPMI 1640 Medium 400 (μg/ml)
COS-1 monkey, African green kidney Dulbecco's modified Eagle's medium 800 (μg/ml)
PC-12 rat adrenal gland; pheochromocytoma Dulbecco's modified Eagle's medium 700 (μg/ml)
293T human Kidney (embryonic) Dulbecco's modified Eagle's medium 400 (μg/ml)
293T human Kidney (embryonic) Dulbecco's modified Eagle's medium 62500 (μg/ml)
MCF7 human pleural effusion (metastasis); adenocarcinoma (mammary gland primary) Dulbecco's modified Eagle's medium 400 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 600 (μg/ml)
MV-4-11 human peripheral blood; biphenotypic B myelomonocytic leukemia RPMI 1640 Medium 400 (μg/ml)
MV-4-11 human peripheral blood; biphenotypic B myelomonocytic leukemia RPMI 1640 Medium 400 (μg/ml)
32D Clone 3 mouse bone marrow 400 (μg/ml)
CHO-K1 hamster, Chinese ovary Dulbecco's modified Eagle's medium 500 (μg/ml)
COS-1 monkey, African green kidney Dulbecco's modified Eagle's medium 600 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 700 (μg/ml)
Raji human B lymphocyte; Burkitt's lymphoma RPMI 1640 Medium 500 (μg/ml)
COS-7 monkey, African green kidney Dulbecco's modified Eagle's medium 50 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 400 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 600 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 600 (μg/ml)
COS-7 monkey, African green kidney Dulbecco's modified Eagle's medium 750 (μg/ml)
70Z/3 mouse pre-B lymphoblast; methylnitrosourea-induced lymphoma Dulbecco's modified Eagle's medium 400 (μg/ml)
COS-7 monkey, African green kidney Dulbecco's modified Eagle's medium 500 (μg/ml)
HeLa human cervix; adenocarcinoma 400 (μg/ml)
SiHa human cervix; squamous cell carcinoma Dulbecco's modified Eagle's medium 800 (μg/ml)
HeLa S3 human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 700 (μg/ml)
HT-1080 human connective tissue; fibrosarcoma Dulbecco's modified Eagle's medium 400 (μg/ml)
U-2 OS human bone; osteosarcoma Dulbecco's modified Eagle's medium 700 (μg/ml)
HeLa S3 human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 400 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 600 (μg/ml)
CHO hamster, Chinese ovary Dulbecco's modified Eagle's medium 750 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 750 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 800 (μg/ml)
GH3 rat pituitary tumor Dulbecco's modified Eagle's medium 1000 (μg/ml)
AKH13 Dulbecco's modified Eagle's medium 800 (μg/ml)
293-H Dulbecco's modified Eagle's medium 800 (μg/ml)
LMTK– Dulbecco's modified Eagle's medium 600 (μg/ml)
INS-1 RPMI 1640 Medium 500 (μg/ml)
LB831-BLC Iscove's minimal essential medium 2000 (μg/ml)
E14-1.1 720 (μg/ml)
SD1 500 (μg/ml)
13-5-1 Ham’s F-12 nutrient mixture 800 (μg/ml)
CHO 22H11 GMEM medium 800 (μg/ml)
HeLa S Dulbecco's modified Eagle's medium 750 (μg/ml)
Jurkat RPMI 1640 Medium 250 (μg/ml)
HL3T1 2000 (μg/ml)
BJAB RPMI 1640 Medium 400 (μg/ml)
Ed141.MEL RPMI 1640 Medium 800 (μg/ml)
Ed147.BT DMEM / F 12 medium 400 (μg/ml)
Ed149.BT DMEM / F 12 medium 800 (μg/ml)
CSM14.1 2000 (μg/ml)
ES cell Dulbecco's modified Eagle's medium 400 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia RPMI 1640 Medium 250 (μg/ml)
13-5-1 500 (μg/ml)
EUFA592 RPMI 1640 Medium 300 (μg/ml)
EUFA816 RPMI 1640 Medium 500 (μg/ml)
EUFA961 RPMI 1640 Medium 250 (μg/ml)
EUFA696 RPMI 1640 Medium 500 (μg/ml)
AG656 RPMI 1640 Medium 500 (μg/ml)
BD952 RPMI 1640 Medium 500 (μg/ml)
EUFA696 RPMI 1640 Medium 1000 (μg/ml)
EUFA543 RPMI 1640 Medium 300 (μg/ml)
MT58 Ham’s F-12 nutrient mixture 700 (μg/ml)
N18TG2 Dulbecco's modified Eagle's medium 500 (μg/ml)
U373 human Glioblastoma-astrocytoma 500 (μg/ml)
C3H10T1/2 mouse embryonic mesenchymal cell line Dulbecco's modified Eagle's medium 500 (μg/ml)
QSG7701 Dulbecco's modified Eagle's medium 500 (μg/ml)
TMK-1 RPMI 1640 Medium 500 (μg/ml)
MEFs Dulbecco's modified Eagle's medium 1000 (μg/ml)
SC-2 Schneider’s insect medium 2000 (μg/ml)
S2-O13 Minimal essential medium 300 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 500 (μg/ml)
Tet-off HT-1080 Dulbecco’s modified minimal essential medium 600 (μg/ml)
UM-SCC 1000 (μg/ml)
HCT 116 human colon; colorectal carcinoma 400 (μg/ml)
N18–RE 105 Dulbecco's modified Eagle's medium 400 (μg/ml)
Pam 212 Eagle's minimal essential medium 300 (μg/ml)
LY-2 Eagle's minimal essential medium 600 (μg/ml)
LY-8 Eagle's minimal essential medium 800 (μg/ml)
HCT 116 human colon; colorectal carcinoma DMEM / F 12 medium 400 (μg/ml)
PS120 500 (μg/ml)
hBRIE 380i-neg Iscove's modified Dulbecco's medium 300 (μg/ml)
Huh-7 Dulbecco's modified Eagle's medium 500 (μg/ml)
Chang Liver human HeLa contaminant Dulbecco's modified Eagle's medium 350 (μg/ml)
MCF-7 human Dulbecco's modified Eagle's medium 600 (μg/ml)
1074MEL RPMI 1640 Medium 600 (μg/ml)
1106MEL RPMI 1640 Medium 500 (μg/ml)
1174MEL RPMI 1640 Medium 500 (μg/ml)
Hep G2 human liver; hepatocellular carcinoma RPMI 1640 Medium 800 (μg/ml)
CCLP1 Dulbecco's modified Eagle's medium 800 (μg/ml)
V79/SD1 Dulbecco's modified Eagle's medium 600 (μg/ml)
CL1-0 RPMI 1640 Medium 500 (μg/ml)
IEC-17 Dulbecco's modified Eagle's medium 1000 (μg/ml)
CL1-5 RPMI 1640 Medium 1000 (μg/ml)
K562-9 RPMI 1640 Medium 1000 (μg/ml)
NIH3T3 mouse embryo 1000 (μg/ml)
MEFs Dulbecco's modified Eagle's medium 1000 (μg/ml)
Evsa-T Dulbecco's modified Eagle's medium 300 (μg/ml)
PC-12 rat adrenal gland; pheochromocytoma Dulbecco's modified Eagle's medium 400 (μg/ml)
β-STC-1 Dulbecco's modified Eagle's medium 400 (μg/ml)
SK-N-SH human bone marrow (metastasis); neuroblastoma (brain primary) Dulbecco's modified Eagle's medium 1000 (μg/ml)
SK-N-MC human supraorbital area (metastasis); neuroepithelioma (brain primary) Dulbecco's modified Eagle's medium 1000 (μg/ml)
SK-N-MC-IXC Dulbecco's modified Eagle's medium 1000 (μg/ml)
LCC-18 RPMI 1640 Medium 400 (μg/ml)
LCC-18 RPMI 1640 Medium 400 (μg/ml)
L929sA Dulbecco's modified Eagle's medium 100 (μg/ml)
IOSE-398 350 (μg/ml)
GH3 rat pituitary tumor Dulbecco's modified Eagle's medium 500 (μg/ml)
OK-P Dulbecco's modified Eagle's medium 800 (μg/ml)
RCC-4 Dulbecco's modified Eagle's medium 100 (μg/ml)
rHSCs Dulbecco's modified Eagle's medium 600 (μg/ml)
LY-B 2000 (μg/ml)
REF Dulbecco's modified Eagle's medium 2000 (μg/ml)
TPC-1 Ham’s F-12 nutrient mixture 2000 (μg/ml)
WRO Ham’s F-12 nutrient mixture 500 (μg/ml)
FRO Ham’s F-12 nutrient mixture 500 (μg/ml)
BCBL-1 RPMI 1640 Medium 1000 (μg/ml)
NPC-KT Dulbecco's modified Eagle's medium 800 (μg/ml)
MDCKts.src 830 (μg/ml)
S100L 830 (μg/ml)
S137L 500 (μg/ml)
LPS449 900 (μg/ml)
FTC-238 830 (μg/ml)
K562 human lymphoblastoid 1000 (μg/ml)
ES cell 700 (μg/ml)
U-937 human macrophage; histiocytic lymphoma α-modified minimal essential medium 400 (μg/ml)
β1A-GD25 Dulbecco's modified Eagle's medium 400 (μg/ml)
GD25T Dulbecco's modified Eagle's medium 1000 (μg/ml)
HUES-7 Dulbecco's modified Eagle's medium 600 (μg/ml)
T47D-Y Minimal essential medium 600 (μg/ml)
T47DC42 Minimal essential medium 150 (μg/ml)
MCF-7C4-12 Minimal essential medium 300 (μg/ml)
HeLa-TO Dulbecco's modified Eagle's medium 1000 (μg/ml)
mature embryos of sgr seeds 1000 (μg/ml)
COS-7 monkey, African green kidney Dulbecco's modified Eagle's medium 500 (μg/ml)
MEFs Dulbecco's modified Eagle's medium 1000 (μg/ml)
RMA-S 500 (μg/ml)
KNS-81 Dulbecco's modified Eagle's medium 1000 (μg/ml)
KM12SM 1000 (μg/ml)
KB-3-1 Dulbecco's modified Eagle's medium 500 (μg/ml)
PC-3M RPMI 1640 Medium 500 (μg/ml)
Co115 RPMI 1640 Medium 500 (μg/ml)
Co115 RPMI 1640 Medium 500 (μg/ml)
Co115 RPMI 1640 Medium 1200 (μg/ml)
ARCaP Dulbecco's modified Eagle's medium 400 (μg/ml)
721.221 RPMI 1640 Medium 1500 (μg/ml)
SGC7901 Dulbecco's modified Eagle's medium 400 (μg/ml)
VSMCs Dulbecco's modified Eagle's medium 400 (μg/ml)
U251 Dulbecco's modified Eagle's medium 400 (μg/ml)
GM5849 Dulbecco's modified Eagle's medium 400 (μg/ml)
GM637 Dulbecco's modified Eagle's medium 400 (μg/ml)
L929 500 (μg/ml)
BE11 1500 (μg/ml)
CMK RPMI 1640 Medium 800 (μg/ml)
GT1-7 Dulbecco's modified Eagle's medium 500 (μg/ml)
AUXB1 500 (μg/ml)
HA1 400 (μg/ml)
GM7372 α-modified minimal essential medium 400 (μg/ml)
DC-3F/ADII 200 (μg/ml)
K562 human lymphoblastoid RPMI 1640 Medium 400 (μg/ml)
L1.2 RPMI 1640 Medium 500 (μg/ml)
ROS 17/2.8 DMEM / F 12 medium 500 (μg/ml)
Jurkat T RPMI 1640 Medium 600 (μg/ml)
Jurkat T RPMI 1640 Medium 600 (μg/ml)
HeLa Tet-On Dulbecco's modified Eagle's medium 500 (μg/ml)
HeLa Tet-On Dulbecco's modified Eagle's medium 500 (μg/ml)
RCCD1 800 (μg/ml)
HHUA Dulbecco's modified Eagle's medium 1200 (μg/ml)
Ishikawa Dulbecco's modified Eagle's medium 500 (μg/ml)
CGR8 BHK21 medium 1000 (μg/ml)
INS-1 832/13 RPMI 1640 Medium 600 (μg/ml)
DO11.10 500 (μg/ml)
CEM/ARAC-8C RPMI 1640 Medium 400 (μg/ml)
BaF3 RPMI 1640 Medium 400 (μg/ml)
High Five 400 (μg/ml)
DCEK.ICAM.Hi7 RPMI 1640 Medium 800 (μg/ml)
3Y1 Dulbecco's modified Eagle's medium 400 (μg/ml)
Ba/F3 RPMI 1640 Medium 800 (μg/ml)
BaF3 800 (μg/ml)
Ba/F3 RPMI 1640 Medium 800 (μg/ml)
NR 500 (μg/ml)
Ba/F3 IL-3 conditioned medium 500 (μg/ml)
Ba/F3 IL-3 conditioned medium 1000 (μg/ml)
SQ20B Dulbecco's modified Eagle's medium 1000 (μg/ml)
IDG26.10-3 1000 (μg/ml)
P1.PyT Dulbecco's modified Eagle's medium 1000 (μg/ml)
BaF3 1000 (μg/ml)
DBA/1 Dulbecco's modified Eagle's medium 800 (μg/ml)
HepKANO 800 (μg/ml)
FDCW2 OPTI-MEM 800 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 800 (μg/ml)
DG44 α-modified minimal essential medium 800 (μg/ml)
PG13 mouse embryo; retroviral packaging line 700 (μg/ml)
HeLa T-REx Dulbecco's modified Eagle's medium 500 (μg/ml)
Jurkat 600 (μg/ml)
K562 human lymphoblastoid RPMI 1640 Medium 800 (μg/ml)
K562 human lymphoblastoid RPMI 1640 Medium 350 (μg/ml)
Psi-2 Dulbecco's modified Eagle's medium 1000 (μg/ml)
PA317 mouse embryo; amphotropic retroviral packaging line Dulbecco's modified Eagle's medium 800 (μg/ml)
HeLa-Munc18b Dulbecco's modified Eagle's medium 1000 (μg/ml)
HEK-293-Munc18b Dulbecco's modified Eagle's medium 10 (μg/ml)
2GP19Talf Dulbecco's modified Eagle's medium 800 (μg/ml)
Schwann cell Dulbecco's modified Eagle's medium 1000 (μg/ml)
AKR-2B Dulbecco's modified Eagle's medium 800 (μg/ml)
PANC-1 human pancreas (duct); epithelioid carcinoma Dulbecco's modified Eagle's medium 800 (μg/ml)
HeLa S3 human cervix; adenocarcinoma Ham’s F-12 nutrient mixture 700 (μg/ml)
HeLa S3 human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 700 (μg/ml)
REF-52 700 (μg/ml)
TM87-16 700 (μg/ml)
STM91-01 700 (μg/ml)
HeLa S3 human cervix; adenocarcinoma 700 (μg/ml)
BCaP-37 400 (μg/ml)
LK2 Dulbecco's modified Eagle's medium 1000 (μg/ml)
L929 Minimal essential medium 800 (μg/ml)
HeLa/CL 12 Dulbecco's modified Eagle's medium 800 (μg/ml)
EcR-293 Dulbecco's modified Eagle's medium 200 (μg/ml)
HeLa Tet-On Dulbecco's modified Eagle's medium 200 (μg/ml)
KYSE RPMI-1640 / Ham's F-12 1000 (μg/ml)
NB4-S1 RPMI 1640 Medium 800 (μg/ml)
RECs 2000 (μg/ml)
Jurkat T RPMI 1640 Medium 500 (μg/ml)
HaCaT Dulbecco's modified Eagle's medium 1000 (μg/ml)
HaCaT Dulbecco's modified Eagle's medium 800 (μg/ml)
Jurkat 600 (μg/ml)
BJAB RPMI 1640 Medium 1000 (μg/ml)
BJAB RPMI 1640 Medium 600 (μg/ml)
A20 mouse B lymphocyte; reticulum cell sarcoma Dulbecco's modified Eagle's medium 1000 (μg/ml)
NPM-ALK Tet-Off MEF DMEM 500 (μg/ml)
 
 
 
This project is supported byTOKU-Ewhich specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
 Cell-Lines | Plasmids | Privacy Policy | Terms of Use | About Us | Contact Us
Cell-Culture Database Version 1.1